The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia
Neuropsychiatric Disease and Treatment · 2023-03 · Volume 19 · 531-545
DOI: 10.2147/ndt.s395383 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2023-03. Verfasst von Ruth Milz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Research & Development LLC, Titusville, NJ, USA. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Janssen Research & Development LLC, Titusville, NJ, USA.
- Janssen-Cilag, Porto Salvo, Portugal.
- Janssen Scientific Affairs, LLC, Raritan, NJ, USA.
- Janssen Cilag, Madrid, Spain.
- Janssen Global Medical Affairs, Cilag, Zug, Switzerland.
- Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Queens, NY, USA.
ORCID-Profile: Jose Antunes, Dean Najarian, Srihari Gopal, John M Kane
Zitieren
APA
Milz, R., Benson, C., Knight, K., Antunes, J., Najarian, D., Lopez Rengel, P. M., Wang, S., Richarz, U., Gopal, S., & Kane, J. M. (2023). The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric Disease and Treatment, Volume 19, 531-545. https://doi.org/10.2147/ndt.s395383
Vancouver
Milz R, Benson C, Knight K, Antunes J, Najarian D, Lopez Rengel PM, et al. The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric Disease and Treatment. 2023;Volume 19:531-545. doi:10.2147/ndt.s395383
BibTeX
@article{Milz2023,
author = {Milz, Ruth and Benson, Carmela and Knight, Karl and Antunes, Jose and Najarian, Dean and Lopez Rengel, Paola-Maria and Wang, Steven and Richarz, Ute and Gopal, Srihari and Kane, John M},
title = {The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia},
journal = {Neuropsychiatric Disease and Treatment},
year = {2023},
volume = {Volume 19},
pages = {531--545},
doi = {10.2147/ndt.s395383}
}
EUVIMED